• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从神经学角度看线粒体疾病。

A neurological perspective on mitochondrial disease.

机构信息

Mitochondrial Research Group, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.

出版信息

Lancet Neurol. 2010 Aug;9(8):829-40. doi: 10.1016/S1474-4422(10)70116-2.

DOI:10.1016/S1474-4422(10)70116-2
PMID:20650404
Abstract

Disruption of the most fundamental cellular energy process, the mitochondrial respiratory chain, results in a diverse and variable group of multisystem disorders known collectively as mitochondrial disease. The frequent involvement of the brain, nerves, and muscles, often in the same patient, places neurologists at the forefront of the interesting and challenging process of diagnosing and caring for these patients. Mitochondrial diseases are among the most frequently inherited neurological disorders, and can be caused by mutations in mitochondrial or nuclear DNA. Substantial progress has been made over the past decade in understanding the genetic basis of these disorders, with important implications for the general neurologist in terms of the diagnosis, investigation, and multidisciplinary management of these patients.

摘要

线粒体呼吸链这一最基本的细胞能量过程的破坏会导致一组不同且多变的多系统疾病,这些疾病统称为线粒体疾病。大脑、神经和肌肉经常同时受到影响,这使得神经科医生处于诊断和治疗这些患者这一有趣且具有挑战性过程的最前沿。线粒体疾病是最常见的遗传性神经疾病之一,可由线粒体或核 DNA 突变引起。在过去的十年中,人们在理解这些疾病的遗传基础方面取得了重大进展,这对一般神经科医生在这些患者的诊断、检查和多学科管理方面具有重要意义。

相似文献

1
A neurological perspective on mitochondrial disease.从神经学角度看线粒体疾病。
Lancet Neurol. 2010 Aug;9(8):829-40. doi: 10.1016/S1474-4422(10)70116-2.
2
The neurology of mitochondrial DNA disease.线粒体DNA疾病的神经学
Lancet Neurol. 2002 Oct;1(6):343-51. doi: 10.1016/s1474-4422(02)00159-x.
3
[Diagnostic investigations of mitochondrial diseases with neurological symptoms].[伴有神经症状的线粒体疾病的诊断研究]
Rev Neurol (Paris). 2007 Feb;163(2):254-63. doi: 10.1016/s0035-3787(07)90400-2.
4
Mitochondrial neurological diseases: a clinician's perspective.线粒体神经疾病:临床医生视角
Neurol India. 2004 Sep;52(3):305-6.
5
Mitochondrial Disorders of the Nervous System: A Review.神经系统的线粒体疾病:综述
Clin Pediatr (Phila). 2019 Apr;58(4):381-394. doi: 10.1177/0009922818821890. Epub 2019 Jan 4.
6
Mitochondrial diseases.线粒体疾病
Handb Clin Neurol. 2018;147:125-141. doi: 10.1016/B978-0-444-63233-3.00010-5.
7
Clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration.患有进行性智力和神经功能衰退的儿童线粒体疾病的临床表现。
Dev Med Child Neurol. 2010 May;52(5):407-8. doi: 10.1111/j.1469-8749.2009.03488.x. Epub 2009 Oct 10.
8
Neurologic disorders due to mitochondrial DNA mutations.由于线粒体 DNA 突变引起的神经紊乱。
Semin Pediatr Neurol. 2012 Dec;19(4):194-202. doi: 10.1016/j.spen.2012.09.006.
9
Prevalence and clinical prediction of mitochondrial disorders in a large neuropediatric cohort.大型神经儿科队列中线粒体疾病的患病率及临床预测。
Clin Genet. 2021 Dec;100(6):766-770. doi: 10.1111/cge.14061. Epub 2021 Sep 19.
10
Mutations causing mitochondrial disease: What is new and what challenges remain?导致线粒体疾病的突变:有哪些新的发现,还有哪些挑战?
Science. 2015 Sep 25;349(6255):1494-9. doi: 10.1126/science.aac7516. Epub 2015 Sep 24.

引用本文的文献

1
Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases.针对神经退行性疾病中线粒体功能障碍的营养保健品策略
Foods. 2025 Jun 23;14(13):2193. doi: 10.3390/foods14132193.
2
Thiosulphate sulfurtransferase: Biological roles and therapeutic potential.硫代硫酸盐硫转移酶:生物学作用及治疗潜力。
Redox Biol. 2025 May;82:103595. doi: 10.1016/j.redox.2025.103595. Epub 2025 Mar 14.
3
Clinical manifestations and pathogenesis of mitochondrial dysfunction in short stature.身材矮小中线粒体功能障碍的临床表现与发病机制。
World J Pediatr. 2025 Mar;21(3):223-251. doi: 10.1007/s12519-025-00881-y. Epub 2025 Feb 26.
4
Polyamine metabolism is dysregulated in COXFA4-related mitochondrial disease.多胺代谢在与COXFA4相关的线粒体疾病中失调。
HGG Adv. 2025 Apr 10;6(2):100418. doi: 10.1016/j.xhgg.2025.100418. Epub 2025 Feb 17.
5
Uncovering protein glycosylation dynamics and heterogeneity using deep quantitative glycoprofiling (DQGlyco).利用深度定量糖谱分析(DQGlyco)揭示蛋白质糖基化动力学和异质性。
Nat Struct Mol Biol. 2025 Feb 10. doi: 10.1038/s41594-025-01485-w.
6
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.线粒体疾病:从分子机制到治疗进展
Signal Transduct Target Ther. 2025 Jan 10;10(1):9. doi: 10.1038/s41392-024-02044-3.
7
Microglia mitochondrial complex I deficiency during development induces glial dysfunction and early lethality.发育过程中小胶质细胞线粒体复合物 I 缺陷会导致神经胶质功能障碍和早期死亡。
Nat Metab. 2024 Aug;6(8):1479-1491. doi: 10.1038/s42255-024-01081-0. Epub 2024 Jul 24.
8
Increased Diagnostic Yield by Reanalysis of Whole Exome Sequencing Data in Mitochondrial Disease.全外显子组测序数据再分析提高线粒体疾病的诊断率。
J Neuromuscul Dis. 2024;11(4):767-775. doi: 10.3233/JND-240020.
9
Harnessing accurate mitochondrial DNA base editing mediated by DdCBEs in a predictable manner.以可预测的方式利用由DdCBE介导的精确线粒体DNA碱基编辑。
Front Bioeng Biotechnol. 2024 Apr 9;12:1372211. doi: 10.3389/fbioe.2024.1372211. eCollection 2024.
10
Focusing on mitochondria in the brain: from biology to therapeutics.关注大脑中的线粒体:从生物学到治疗学。
Transl Neurodegener. 2024 Apr 17;13(1):23. doi: 10.1186/s40035-024-00409-w.